Elphis Cell Therapeutics
PrivateLast Round
Series A
Extension
Jan 21, 2024
Total Funding Raised
$6.72M
Company Overview
Elphis Cell Therapeutics is a biotechnology company that develops personalized cell therapies for intractable vascular diseases using complex stem cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elphis Cell Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Elphis Cell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 21, 2024 | ||||
| Series A | Oct 12, 2023 |
Elphis Cell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BSK Investment | Series A |
| Pathfinder H | Series A Extension, Series A |
| The Turning Point | Series A |
| Daekyo Investment | Series A, Series A Extension |
| LK Technology Investment | Series A |
Elphis Cell Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elphis Cell Therapeutics's valuation, stock price, and market status.
